The estimated Net Worth of Vinita D Gupta is at least $703 Thousand dollars as of 9 March 2024. Ms. Gupta owns over 106,837 units of Precigen Inc stock worth over $396,310 and over the last 8 years she sold PGEN stock worth over $0. In addition, she makes $306,495 as Independent Director at Precigen Inc.
Sign up
Ms. Gupta PGEN stock SEC Form 4 insiders trading
Vinita has made over 7 trades of the Precigen Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently she exercised 106,837 units of PGEN stock worth $103,632 on 9 March 2024.
The largest trade she's ever made was exercising 106,837 units of Precigen Inc stock on 9 March 2024 worth over $103,632. On average, Vinita trades about 13,876 units every 120 days since 2017. As of 9 March 2024 she still owns at least 408,567 units of Precigen Inc stock.
You can see the complete history of Ms. Gupta stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Vinita Gupta biography
Vinita D. Gupta serves as Independent Director of the Company. Ms. Gupta has served as a Board member since April 2017. Since September 2012, Ms. Gupta has served as the Chief Executive Officer of Lupin Limited (“Lupin”). Lupin, headquartered in Mumbai, India, is an innovation led global pharmaceutical company developing and delivering a wide range of branded and generic formulations, biotechnology products, and APIs. Ms. Gupta has served as a director of Lupin since 2001 and serves on its Risk Management Committee. In addition, Ms. Gupta has served as the Chief Executive Officer and chairperson of Lupin Pharmaceuticals, Inc., the U.S. wholly owned subsidiary of Lupin, since 2003. Ms. Gupta served as director on the board of Lupin’s Japanese subsidiary Kyowa Pharmaceuticals from 2007 until the sale of that business in 2019. Ms. Gupta has held various positions at Lupin since joining the company in 1993. Ms. Gupta was named 2015 Ernst & Young Entrepreneur of the Year and won the 2016 Forbes India Leadership Awards – Entrepreneur of the Year. Ms. Gupta is regularly named in Forbes Asia Top 50 Power Business women listings for Asia Pacific. Ms. Gupta graduated from the University of Mumbai with a degree in pharmacy and received her MBA from the Kellogg School of Management at Northwestern University.
What is the salary of Vinita Gupta?
As the Independent Director of Precigen Inc, the total compensation of Vinita Gupta at Precigen Inc is $306,495. There are 12 executives at Precigen Inc getting paid more, with Randal Kirk having the highest compensation of $2,067,620.
How old is Vinita Gupta?
Vinita Gupta is 52, she's been the Independent Director of Precigen Inc since 2017. There are 14 older and 4 younger executives at Precigen Inc. The oldest executive at Precigen Inc is Robert Shapiro, 81, who is the Lead Independent Director.
Insiders trading at Precigen Inc
Over the last 5 years, insiders at Precigen Inc have traded over $44,216,787 worth of Precigen Inc stock and bought 52,689,457 units worth $114,197,137 . The most active insiders traders include Randal J Kirk, Trading S.A. Ares, and Helen Sabzevari. On average, Precigen Inc executives and independent directors trade stock every 9 days with the average trade being worth of $358,866. The most recent stock trade was executed by Randal J Kirk on 9 August 2024, trading 23,529,411 units of PGEN stock currently worth $19,999,999.
What does Precigen Inc do?
precigen, inc. discovers and develops the next generation of gene and cellular therapies in the united states. it also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. in addition, the company offers ultravector platform that incorporates advanced dna construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbil15, a gene that enhances functional characteristics of immune cells; sleeping beauty, a non-viral transposon/transposase system; attsite recombinases, which breaks and rejoins dna at specific sequences; adenoverse technology platform, a library of engineered adenovector serotypes; and l. lactis is a food-grade bacterium. additionally, it provides rheoswitch inducible gene switch that provides qua
What does Precigen Inc's logo look like?
Complete history of Ms. Gupta stock trades at Precigen Inc
Precigen Inc executives and stock owners
Precigen Inc executives and other stock owners filed with the SEC include:
-
Randal Kirk,
Executive Chairman of the Board -
Dr. Helen Sabzevari MPH, Ph.D.,
Pres, CEO & Director -
Donald Lehr,
Chief Legal Officer -
Rick Sterling,
Chief Financial Officer -
Jeffrey Perez,
Senior Vice President - Intellectual Property Affairs -
Helen Sabzevari,
President, Chief Executive Officer, President - Precigen, Inc. -
Donald P. Lehr,
Chief Legal Officer & Corp. Sec. -
Jeffrey Thomas Perez,
Sr. VP of Intellectual Property Affairs -
Jeffrey Kindler,
Independent Director -
Robert Shapiro,
Lead Independent Director -
Cesar Alvarez,
Independent Director -
James Turley,
Independent Director -
Dean Mitchell,
Independent Director -
Fred Hassan,
Independent Director -
Vinita Gupta,
Independent Director -
Steven Frank,
Independent Director -
Marie Rossi,
VP of Communications -
Steven Harasym,
Head of Investor Relations -
James Vincent Lambert,
Interim Principal Accounting Officer -
Rutul R. Shah,
Head of Operations & Portfolio -
Harry Thomasian Jr.,
Chief Financial Officer -
Dr. Thomas D. Reed,
Founder & Chief Science Officer -
Randal J. Kirk,
Exec. Chairman -
Harry Jr. Thomasian,
Chief Financial Officer -
Nancy H Agee,
Director -
Rutul R Shah,
Chief Operating Officer -
D. Bradford Osborne,
VP, Finance and Accounting -
Trading S.A. Ares,
10% owner -
Phil Tennant,
Chief Commercial Officer